CBIO

Crescent Biopharma
CBIO

Overview Fund Trends Analyst Outlook Journalist POV

36 hedge funds and large institutions have $230M invested in Crescent Biopharma in 2014 Q1 according to their latest regulatory filings, with 36 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
36
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$140M
2
+$40M
3
+$14.6M
4
CAM
Cormorant Asset Management
Massachusetts
+$7.67M
5
DCM
Driehaus Capital Management
Illinois
+$3.88M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$140M
2
$40M
3
$14.6M
4
$7.67M
5
$3.88M
6
$3.62M
7
$2.45M
8
$2.05M
9
$1.75M
10
$1.73M
11
$1.27M
12
$1.23M
13
$1.18M
14
$1.06M
15
$918K
16
$754K
17
$728K
18
$698K
19
$528K
20
$495K
21
$477K
22
$468K
23
$335K
24
$334K
25
$323K
1
2